Blood Cancer United, Inc.

Name

Blood Cancer United, Inc.

Legal name

Blood Cancer United, Inc.

Website

https://bloodcancerunited.org

Company type

Private

Founded year

1949

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Blood Cancer United is a 501(c)(3) patient advocacy nonprofit that funds blood cancer research, provides free patient support services, and distributes financial assistance across the U.S. and Canada via a $500M annual budget and 80+ offices.

Ownership category

akta.pro rank

Product category

Blood Cancer Nonprofit Patient Advocacy and Research Services

NAICS

Voluntary Health Organizations (813212), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Blood, Organ & Tissue Donation Organizations (BPAGACAJ)

akta.pro secondary industries

Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL), Clinical Research Support (CRC/CTA) (EDAOAJAO)

Keywords

• Blood cancer research
• Patient financial assistance
• Clinical trial support
• Nonprofit health advocacy
• Peer-to-peer fundraising

Headquarters

HQ city

White Plains

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Technology or R&D, Others

Revenue model

1. Individual Donations: Blood Cancer United receives tax-deductible donations from individuals supporting blood cancer research and patient services. The organization runs direct mail campaigns, online donation portals, and monthly giving programs.
2. Corporate Partnerships: Corporate partners sponsor events, fund programs, and provide financial support. National partners include Subaru, iHop, Unleashed Brands Foundation, Enmarket, and GiveByCruising. Partners engage through Cause marketing, employee giving, and event sponsorships.
3. Peer-to-Peer Fundraising Events: The organization generates revenue through participant-driven fundraising events including Light The Night, Big Climb, Team In Training, Visionaries of the Year, Student Visionaries of the Year, and America's Most Beautiful Bike Ride. These events mobilize volunteers to raise funds from their personal networks.
4. Planned Giving and Bequests: The organization accepts wills, annuities, and other planned gifts through its legacy giving program.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Blood Cancer United is a nonprofit patient advocacy organization that delivers free patient support, financial assistance, and education to blood cancer patients and families while funding more than $2 billion of research across 100+ blood cancer types. Its portfolio includes the Beat AML and PedAL Master Clinical Trials, the Therapy Acceleration Program biotech investment mechanism, and coordinated federal/state policy advocacy aimed at improving treatment access and affordability.

Product overview

Blood Cancer United (formerly The Leukemia & Lymphoma Society) is a nonprofit patient advocacy organization offering a comprehensive suite of patient support, financial assistance, research funding, and advocacy services for blood cancer patients. The organization operates multiple interconnected programs: patient support services including Information Specialists and the Clinical Trial Support Center; financial assistance programs including Co-Pay Assistance, Travel Assistance, and Urgent Need Programs; research initiatives including the Beat AML and PedAL Master Clinical Trials and Therapy Acceleration Program; and educational resources including publications, webcasts, and mobile apps. The Dare to Dream Project focuses specifically on transforming pediatric blood cancer treatment. The organization does not offer a technology platform or SaaS product but provides direct patient services and advocacy.

Differentiator

Problem solved

Functional benefit

Brands

• Light The Night: Nationwide evening walk event bringing communities together to illuminate the path toward blood cancer cures, featuring lantern-themed symbolism honoring supporters, survivors, and loved ones lost.
• Big Climb
• Visionaries of the Year
• Student Visionaries of the Year
• Beat AML Master Clinical Trial
• PedAL Master Clinical Trial
• Dare to Dream Project
• Therapy Acceleration Program (TAP)
• Team In Training
• America's Most Beautiful Bike Ride
• Health Manager
• Coloring for Kids

Products and services

• Patient Support Services Free personalized information and support services for blood cancer patients and caregivers, including one-on-one assistance from oncology social workers and nurses, clinical trial support, nutritional consultations, and peer-to-peer support. Intended for individuals diagnosed with any of the 100+ types of blood cancer and their family caregivers.
• Clinical Trial Support Center (CTSC) Registered nurses with blood cancer expertise assist patients and caregivers throughout the clinical trial process by conducting comprehensive clinical trial searches and providing navigation support. Intended for blood cancer patients considering or enrolling in clinical trials.
• Financial Assistance Programs Suite of direct-to-patient financial assistance programs including Patient Aid ($100), Co-Pay Assistance, Local Financial Assistance ($500), Travel Assistance ($500–$2,500), Urgent Need ($500), Susan Lang Pay-It-Forward Patient Travel Assistance, Susan Lang Pre CAR T-cell Therapy Travel Assistance, Medical Debt Case Management, Scholarships for Blood Cancer Survivors, and the Veterans Dental Partnership. Intended for blood cancer patients meeting income eligibility at or below 600% of the Federal Poverty Level.
• Information Specialists Highly trained oncology social workers and nurses provide free personalized assistance to patients and families with disease and treatment information via a toll-free hotline (1-800-955-4572), live chat, and email. Intended for blood cancer patients, survivors, caregivers, and healthcare professionals.
• Beat AML Master Clinical Trial Precision medicine master clinical trial program sponsored by Blood Cancer United that brings together multiple targeted therapies and researchers to evaluate treatments matched to acute myeloid leukemia patients' biology. Includes collaboration with AVEO Oncology's Phase 1b/2 trial of ficlatuzumab with azacitidine and venetoclax in patients 60+.
• PedAL Master Clinical Trial First integrated global pediatric acute leukemia master clinical trial testing new, safer therapies matched to children based on their unique biology. Part of the Dare to Dream Project.
• Therapy Acceleration Program (TAP) Strategic initiative funding innovative blood cancer therapies and supporting biotech companies developing new treatments, including participation in Crossbow Therapeutics' $77 million Series B funding round.
• Dare to Dream Project $175 million capital campaign to transform pediatric blood cancer treatment and care, prioritizing cutting-edge research and safer therapies for children. Encompasses the PedAL Master Clinical Trial and pediatric-focused research funding.
• Policy and Advocacy Advocacy initiatives driving policy changes at state and federal levels to accelerate development of new treatments, improve health insurance quality, ensure Medicaid stability, reduce cost of cancer care, and break down barriers to clinical trial access. Includes the Mobile Action Network for individual advocates.
• Educational Resources Free publications, webcasts, videos, podcasts, blood cancer conferences, 3D model library, and educational booklets covering emerging blood cancer therapies, survivorship, nutrition, and caregiver tips. Includes the Blood Cancer Drug Listing covering nearly 200 cancer drugs.
• Patient Registry Registry connecting blood cancer patients with clinical trials and research opportunities, including a pediatric AML real-world data registry developed with Tempus AI using the 'olivia' personal health concierge app and 'Lens' cloud analytics workspace.
• Health Manager Mobile App Mobile application providing patients with tools to track and manage their blood cancer care journey and health information.
• Coloring for Kids Mobile App Mobile application designed for children to provide creative activities during cancer treatment.
• Blood Cancer Drug Listing Detailed reference database covering nearly 200 cancer drugs, including brand and generic names, intended treatments, administration methods, and possible side effects.

Named customers5 records

Segments1 record

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core.

• BeOne MedicinescoreStrategic or Co-development Partner · 24 June 2026Expanded three-year partnership with BeOne Medicines (formerly ONC) committing $5 million over three years to support patient education, community engagement, and the blood cancer care continuum. Builds on more than $3.2 million invested since 2022. Programs include expert-led educational webcasts, Clinical Trial Support Center, and Light The Night community events.
• Tempus AIcoreStrategic or Co-development Partner · 17 March 2026Collaboration to develop one of the largest pediatric acute myeloid leukemia (pAML) real-world data registries. Utilizes Tempus' AI-enabled personal health concierge app 'olivia' and cloud-based analytics workspace 'Lens.' Registry will combine patient-reported outcomes with de-identified medical and genomic data to create external control arms for clinical trials.
• University of Colorado Anschutz (Gates Institute)coreStrategic or Co-development Partner · 14 January 2026$1 million grant awarded to advance first-in-human Phase 1 clinical trial of novel anti-CD64 CAR T-cell therapy for treatment-resistant acute myeloid leukemia. Fully developed by CU Anschutz researchers.
• AVEO Oncology (LG Chem)coreStrategic or Co-development Partner · 14 January 2026Collaboration within Blood Cancer United's Beat AML Master Clinical Trial. AVEO Oncology is conducting a Phase 1b/2 trial evaluating ficlatuzumab in combination with azacitidine and venetoclax for untreated AML in patients 60 years and older.
• The US Oncology NetworkcoreStrategic or Co-development Partner · 15 October 2025Two-year pilot program to improve access to clinical trials for blood cancer patients in select community cancer centers. Expands patient education, clinical trial matching, and navigation services.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• American Cancer Society: The American Cancer Society is the largest voluntary health organization in the US, funding cancer research, providing patient support, and running nationwide fundraising events. It overlaps directly with Blood Cancer United in mission, donor base, and peer-to-peer fundraising model, but operates across all cancer types rather than specializing in blood cancer.
• American Heart Association: The American Heart Association is a large voluntary health organization funding cardiovascular research and running national peer-to-peer fundraising events (Heart Walk). It is comparable to Blood Cancer United in scale, governance, donor base, and event-driven fundraising model, with Blood Cancer United's CRO having previously led Heart Walk field revenue.

Direct peers

• St. Jude Children's Research Hospital: St. Jude is a leading pediatric cancer research and treatment institution with a national fundraising apparatus (ALSAC). It is directly comparable to Blood Cancer United's pediatric mission, particularly the PedAL Master Clinical Trial and Dare to Dream Project, competing for pediatric cancer research funding and donor mindshare.
• Susan G. Komen: Susan G. Komen is a disease-specific nonprofit that funds breast cancer research, provides patient support, and runs iconic peer-to-peer fundraising events (Race for the Cure). It mirrors Blood Cancer United's structure of disease-specific research funding, patient financial assistance, and nationwide event-based fundraising.
• V Foundation for Cancer Research: The V Foundation is a cancer-focused nonprofit that funds translational cancer research through competitive grants. It is directly comparable to Blood Cancer United's research-funding mandate and Beat AML / PedAL Master Clinical Trial activities, competing for the same donor pool supporting cancer research.
• Alex's Lemonade Stand Foundation: Alex's Lemonade Stand Foundation is a pediatric cancer nonprofit funding research and providing family support services. It directly overlaps with Blood Cancer United's Dare to Dream Project and pediatric AML/ALL research portfolio, competing for pediatric cancer research dollars and donor attention.
• National Marrow Donor Program / Be The Match: Be The Match operates the US national marrow donor registry and supports blood cancer patients through transplant-related services. It is comparable to Blood Cancer United's Clinical Trial Support Center and patient navigation services for leukemia, lymphoma, and myeloma patients, particularly around CAR T-cell and stem cell therapies.
• Leukemia Research Foundation: The Leukemia Research Foundation is a disease-specific nonprofit funding blood cancer research and providing patient financial assistance. It directly competes with Blood Cancer United for blood cancer research grants, donor dollars, and patient support engagement.

Emerging players

• Dana-Farber Cancer Institute: Dana-Farber is a leading cancer treatment and research center that conducts blood cancer clinical trials and accepts philanthropic support for research. It is comparable to Blood Cancer United as a partner and competitor in advancing blood cancer research through donor-funded programs and clinical trial infrastructure.
• Memorial Sloan Kettering Cancer Center: Memorial Sloan Kettering is a leading cancer research and treatment institution where Blood Cancer United's CEO previously trained. It overlaps with Blood Cancer United in blood cancer research priorities, clinical trial execution, and donor engagement for pediatric and adult hematologic malignancies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments21 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Blood Cancer United, Inc.